Rinvoq ER 15 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQJLX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $93,820
Award facts
- Contract value 100% obligated
- $93,820.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $93,820.27 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 5, 2025, with completion scheduled for September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical vendor supplying pharmaceuticals and medical supplies to Defense Health Agency, military healthcare systems, the U.S. Coast Guard, and other government entities. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for RINVOQ ER, a targeted immunosuppressant medication, exemplifies the company's role in fulfilling specialized pharmaceutical requirements within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FQJLX?
SPE2DB25FQJLX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FQJLX worth?
The government has obligated $93,820 on SPE2DB25FQJLX.
Is contract SPE2DB25FQJLX an order under another contract?
Yes. SPE2DB25FQJLX is a delivery order under SPE2DB25D3005, an indefinite delivery contract.
Was contract SPE2DB25FQJLX competed?
The extent of competition for SPE2DB25FQJLX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award